Barely Significant
← all excerpts

Sustained-release fampridine (4-aminopyridine) in multiple sclerosis: efficacy and impact on motor function.

Drugs R D · 2013 · PMC3784065 · PMID 23873597

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not achieve significancep > 0.05actually significant
The correlations between MAS change and change in walking speed and endurance did not achieve significance ( p > 0.05).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.